Clinical Trial Update: A Study of Barzolvolimab in Patients With Prurigo Nodularis [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial of Barzolvolimab for prurigo nodularis and indicates the study is currently not actively recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Barzolvolimab (barzolvolimab)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Prurigo Nodularis | Phase 2 | Status: ACTIVE_NOT_RECRUITING